Andrea Biffi Net Worth

The estimated Net Worth of Andrea Biffi is at least $294 mil dollars as of 3 March 2023. Mr. Biffi owns over 293,077 units of Asensus Surgical Inc stock worth over $171,450 and over the last 9 years he sold ASXC stock worth over $0. In addition, he makes $122,055 as Independent Director at Asensus Surgical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Biffi ASXC stock SEC Form 4 insiders trading

Andrea has made over 4 trades of the Asensus Surgical Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 293,077 units of ASXC stock worth $208,085 on 3 March 2023.

The largest trade he's ever made was buying 293,077 units of Asensus Surgical Inc stock on 3 March 2023 worth over $208,085. On average, Andrea trades about 25,465 units every 133 days since 2015. As of 3 March 2023 he still owns at least 492,815 units of Asensus Surgical Inc stock.

You can see the complete history of Mr. Biffi stock trades at the bottom of the page.

Andrea Biffi biography

Andrea Biffi serves as Independent Director of the Company. Mr. Biffi is currently the Chief Executive Officer of Sofar S.p.A. (“Sofar”), a position he has held since June 2015, and he has served as a member of the board of directors of Sofar since November 2012. Mr. Biffi has worked for Sofar, or companies owned by Sofar, since January 2008. Prior to becoming Chief Executive Officer, Mr. Biffi was General Manager of Sofar from November 2012 until June 2015. From January 2008 until November 2013, Mr. Biffi served as General Manager of SOVETA BALTICA UAB, a Lithuanian subsidiary of Sofar, and different positions as a director of Sofar. Since the date of its incorporation in February 2013, Mr. Biffi has served as CEO and President of Sofar Swiss S.A., and since March 2016, he has served as Chairman of the board of directors of Sofar Americas Inc. Since December 2017, Mr. Biffi has served as President and board member of 1LAB SA. Since the date of its incorporation in October 2018, Mr. Biffi has served as sole director of BLL Invest srl. Mr. Biffi’s knowledge of the development of the Senhance System, his extensive business experience in Europe and his chief executive officer experience in the pharmaceutical industry are skills he uses to play an integral role on our Board.

What is the salary of Andrea Biffi?

As the Independent Director of Asensus Surgical Inc, the total compensation of Andrea Biffi at Asensus Surgical Inc is $122,055. There are 8 executives at Asensus Surgical Inc getting paid more, with Anthony Fernando having the highest compensation of $2,176,430.

How old is Andrea Biffi?

Andrea Biffi is 38, he's been the Independent Director of Asensus Surgical Inc since 2018. There are 12 older and no younger executives at Asensus Surgical Inc. The oldest executive at Asensus Surgical Inc is William Kelley, 80, who is the Independent Director.

What's Andrea Biffi's mailing address?

Andrea's mailing address filed with the SEC is C/O ASENSUS SURGICAL, INC., 1 TW ALEXANDER DRIVE, SUITE 160, DURHAM, NC, 27703.

Insiders trading at Asensus Surgical Inc

Over the last 11 years, insiders at Asensus Surgical Inc have traded over $32,677,440 worth of Asensus Surgical Inc stock and bought 7,457,173 units worth $15,992,743 . The most active insiders traders include Jane Ph D Hsiao, Anthony C. J. Fernando y William N Jr Starling. On average, Asensus Surgical Inc executives and independent directors trade stock every 46 days with the average trade being worth of $97,582. The most recent stock trade was executed by Rampertab Shameze on 21 April 2024, trading 81,521 units of ASXC stock currently worth $28,361.

What does Asensus Surgical Inc do?

asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.

Complete history of Mr. Biffi stock trades at Asensus Surgical Inc

Asensus Surgical Inc executives and stock owners

Asensus Surgical Inc executives and other stock owners filed with the SEC include:

• Anthony Fernando,
  President, Chief Executive Officer, Director
• Anthony Fernando,
  Pres, CEO & Director
• Shameze Rampertab B.Sc. MBA, CA, CPA,
  Exec. VP & CFO
• Paul LaViolette,
  Independent Chairman of the Board
• Richard Pfenniger,
  Independent Director
• David Milne,
  Independent Director
• William Starling,
  Independent Director
• William Kelley,
  Independent Director
• Jane Hsiao,
  Independent Director
• Andrea Biffi,
  Independent Director
• Shameze Rampertab,
  Chief Financial Officer, Executive Vice President
• Dr. Stephanie M. Fitts,
  VP of Clinical, Quality and Regulatory Affairs
• Amanda Owens,
  Global Head of People
• Paul Ziegler Jr.,
  VP of Sales
• Joshua B. Weingard,
  Chief Legal Officer & Sec.
• Eric A Smith,
  Chief Commercial Officer
• Joseph P Slattery,
  EVP and CFO
• Aftab Kherani,
  Director
• Willam N Kelley,
  Director
• Todd Pope,
  President and CEO
• S.P.A Sofar,,
  10% owner
• Brett Farabaugh,
  Interim CFO
• Capital Iii Lp Aisling Capi...,
  
• Iv, Llcsv Life Sciences Fun...,
  
• Dennis Dougherty,
  Director
• Richard Mueller,
  Chief Operating Officer
• Kevin J Hobert,
  Director
• Elizabeth Kwo,
  Director